p53-induced inhibition of protein synthesis is independent of apoptosis

European Journal of Biochemistry

Volumn 270, Issue 15, 2003, Pages 3122-3132

  Constantinou, Constantina ^a   Bushell, Martin ^a,d   Jeffrey, Ian W ^a   Tilleray, Vivienne ^a   West, Matthew ^a   Frost, Victoria ^b,e   Hensold, Jack ^c   Clemens, Michael J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Caspases; Erythroleukaemia; p53; Protein synthesis; Temperature sensitive mutants

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; ERYTHROPOIETIN; INITIATION FACTOR; INITIATION FACTOR 4B; INITIATION FACTOR 4GI; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; METABOLIC INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; TRANSLATION INITIATION;

ANIMALS; APOPTOSIS; CASPASES; CELL DIVISION; EUKARYOTIC INITIATION FACTOR-4F; MICE; MUTATION; PROTEIN BIOSYNTHESIS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MURINAE;

EID: 0042268508     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03687.x     Document Type: Article

References (88)

1. Johnson, P., Gray, D., Mowat, M. & Benchimol, S. (1991) Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol. Cell Biol. 11, 1-11.
2. Burns, T.F. & El-Deiry, W.S. (1999) The p53 pathway and apoptosis. J. Cell. Physiol. 181, 231-239.
3. Sionov, R.V. & Haupt, Y. (1999) The cellular response to p53: the decision between life and death. Oncogene 18, 6145-6157.
4. Appella, E. (2001) Modulation of p53 function in cellular regulation. Eur. J. Biochem. 268, 2763-2763.
5. Vousden, K.H. (2000) p53: death star. Cell 103, 691-694.
6. Farrell, P.J., Allan, G.J., Shanahan, F., Vousden, K.H. & Crook, T. (1991) p53 Is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 10, 2879-2887.
7. Bates, S. & Vousden, K.H. (1999) Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55, 28-37.
8. Wang, X.W. (1999) Role of p53 and apoptosis in carcinogenesis. Anticancer Res. 19, 4759-4771.
9. Owen-Schaub, L.B., Zhang, W., Cusack, J.C., Angelo, L.S., Santee, S.M., Fujiwara, T., Roth, J.A., Deisseroth, A.B., Zhang, W.W., Kruzel, E. & Radinsky, R. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol. 15, 3032-3040.
10. Miyashita, T. & Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
11. Kato, M.V., Sato, H., Anzai, H., Nagayoshi, M. & Ikawa, Y. (1997) Up-regulation of cell cycle-associated genes by p53 in apoptosis of an erythroleukemic cell line. Leukemia 11, 389-392.
12. Tokino, T. & Nakamura, Y. (2000) The role of p53-target genes in human cancer. Crit. Rev. Oncol. Hematol. 33, 1-6.
13. 1 arrest. Mol. Cell Biol. 15, 6045-6054.
14. Ewen, M.E. & Miller, S.J. (1996) p53 and translational control. Biochim. Biophys. Acta Rev. Cancer 1242, 181-184.
15. Fontoura, B.M.A., Atienza, C.A., Sorokina, E.A., Morimoto, T. & Carroll, R.B. (1997) Cytoplasmic p53 polypeptide is associated with ribosomes. Mol. Cell Biol. 17, 3146-3154.
16. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J.C. & Levine, A.J. (1994) The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell Biol. 14, 7414-7420.
17. 1 cell-cycle arrest. Genes Dev. 9, 204-217.
18. Miller, S.J., Suthiphongchai, T., Zambetti, G.P. & Ewen, M.E. (2000) p53 binds selectively to the 5′ untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor β- and p53-mediated translational inhibition of Cdk4. Mol. Cell Biol. 20, 8420-8431.
19. Galy, B., Créancier, L., Zanibellato, C., Prats A.C. & Prats, H. (2001) Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene 20, 1669-1677.
20. Galy, B., Créancier, L., Prado-Lourenco, L., Prats, A.-C. & Prats, H. (2001) p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 20, 4613-4620.
21. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F. & Deppert, W. (1995) Negative feedback regulation of wildtype p53 biosynthesis. EMBO J. 14, 4442-4449.
22. Horton, L.E., Bushell, M., Barth-Baus, D., Tilleray, V.J., Clemens, M.J. & Hensold, J. (2002) p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene 21, 5325-5334.
23. Michalovitz, D., Halevy, O. & Oren, M. (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62, 671-680.
24. Clemens, M.J., Bushell, M. & Morley, S.J. (1998) Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17, 2921-2931.
25. Marissen, W.E. & Lloyd, R.E. (1998) Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol. Cell Biol. 18, 7565-7574.
26. Bushell, M., McKendrick, L., Janicke, R.U., Clemens, M.J. & Morley, S.J. (1999) Caspase-3 is necessary and sufficient for cleavage of protein synthesis eukaryotic initiation factor 4G during apoptosis. FEBS Lett. 451, 332-336.
27. Bushell, M., Poncet, D., Marissen, W.E., Flotow H., Lloyd, R.E., Clemens, M.J. & Morley, S.J. (2000) Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis: characterisation of an internal fragment generated by caspase-3-mediated cleavage. Cell Death Differ. 7, 628-636.
28. Bushell, M., Wood, W., Clemens, M.J. & Morley, S.J. (2000) Changes in integrity and association of eukaryotic protein synthesis initiation factors during apoptosis. Eur. J. Biochem. 267, 1083-1091.
29. Bushell, M., Wood, W., Carpenter, G., Pain, V.M., Morley, S.J. & Clemens, M.J. (2001) Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly (A)-binding protein by caspase- and viral protease-mediated cleavages. J. Biol. Chem. 276, 23922-23928.
30. Johnson, P., Chung, S. & Benchimol, S. (1993) Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell Biol. 13, 1456-1463.
31. Spector, D.L., Goldman, R.D. & Leinwand, L.A. (1998) Cells: a Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
32. Morley, S.J., McKendrick, L. & Bushell, M. (1998) Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase. FEBS Lett. 438, 41-48.
33. Morley, S.J., Jeffrey, I., Bushell, M., Pain, V.M. & Clemens, M.J. (2000) Differential requirements for caspase-8 activity in the mechanism of phosphorylation of eIF2α, cleavage of eIF4GI and signaling events associated with the inhibition of protein synthesis in apoptotic Jurkat T cells. FEBS Lett. 477, 229-236.
34. KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis. Oncogene 19, 3115-3120.
35. KIP1 in transformed lymphoid cells. Oncogene 20, 2737-2748.
36. Martinez, J., Georgoff, I. & Levine, A.J. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5, 151-159.
37. Yamato, K., Yamamoto, M., Hirano, Y. & Tsuchida, N. (1995) A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene 11, 1-6.
38. Kato, M.V. (1999) The mechanisms of death of an erythroleukemic cell line by p53: involvement of the microtubule and mitochondria. Leuk. Lymphoma 33, 181-186.
39. Jeffrey, I.W., Bushell, M., Tilleray, V.J., Morley, S. & Clemens, M.J. (2002) Inhibition of protein synthesis in apoptosis: Differential requirements by the tumour necrosis factor α family and a DNA damaging agent for caspases and the double-stranded RNA-dependent protein kinase. Cancer Res. 62, 2272-2280.
40. Lotem, J. & Sachs, L. (1996) Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl Acad. Sci. USA 93, 12507-12512.
41. Yuan, X.M., Li, W., Dalen, H., Lotem, J., Kama, R., Sachs, L. & Brunk, U.T. (2002) Lysosomal destabilization in p53-induced apoptosis. Proc. Natl Acad. Sci. USA 99, 6286-6291.
42. Abrahamson, J.L., Lee, J.M. & Bernstein, A. (1995) Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor. Mol. Cell Biol. 15, 6953-6960.
43. Li, P.F., Dietz, R. & von Harsdorf, R. (1999) p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18, 6027-6036.
44. Gao, C.F., Ren, S., Zhang, L., Nakajima, T., Ichinose, S., Hara, T., Koike, K. & Tsuchida, N. (2001) Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp. Cell Res. 265, 145-151.
45. Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M.P., Mitsuda, N. & Tohyama, M. (2001) Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276, 5256-5264.
46. Di Bacco, A.M.A. & Cotter, T.G. (2002) p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases. Br. J. Haematol. 117, 588-597.
47. Lutzker, S.G., Mathew, R. & Taller, D.R. (2001) A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells. Oncogene 20, 2982-2986.
48. Lakin, N.D. & Jackson, S.P. (1999) Regulation of p53 in response to DNA damage. Oncogene 18, 7644-7655.
49. Oren, M. (1999) Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274, 36031-36034.
50. Xie, S., Wu, H., Wang, Q., Cogswell, J.P., Husain, I., Conn, C.W., Stambrook, P., Jhanwar-Uniyal, M. & Dai, W. (2001) Plk3 links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J. Biol. Chem. 276, 43305-43312.
51. Ryan, K.M., Phillips, A.C. & Vousden, K.H. (2001) Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337.
52. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849.
53. Rodriguez-Lopez, A.M., Xenaki, D., Eden, T.O., Hickman, J.A. & Chresta, C.M. (2001) MDM2-mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells. Mol. Pharmacol. 59, 135-143.
54. Marchenko, N.D., Zaika, A. & Moll, U.M. (2000) Death signal-induced localization of p53 protein to mitochondria - a potential role in apoptotic signaling. J. Biol. Chem. 275, 16202-16212.
55. Caelles, C., Helmberg, A. & Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-223.
56. Gao, C. & Tsuchida, N. (1999) Activation of caspases in p53-induced transactivation-independent apoptosis. Jpn. J. Cancer Res. 90, 180-187.
57. Ding, H.F., Lin, Y.L., McGill, G., Juo, P., Zhu, H., Blenis, J., Yuan, J.Y. & Fisher, D.E. (2000) Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J. Biol. Chem. 275, 38905-38911.
58. Pyronnet, S., Dostie, J. & Sonenberg, N. (2001) Suppression of cap-dependent translation in mitosis. Genes Dev. 15, 2083-2093.
59. Pyronnet, S. & Sonenberg, N. (2001) Cell-cycle-dependent translational control. Curr. Opin. Genet. Dev. 11, 13-18.
60. Clemens, M.J., Bushell, M., Jeffrey, I.W., Pain, V.M. & Morley, S.J. (2000) Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. 7, 603-615.
61. David-Pfeuty, T., Nouvian-Dooghe, Y., Sirri, V., Roussel, P. & Hernandez-Verdun, D. (2001) Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells. Oncogene 20, 5951-5963.
62. Nevins, T.A., Harder, Z.M., Korneluk, R.G. & Holcik, M. (2003) Distinct regulation of internal ribosome entry site-mediated translation following cellular stress is mediated by apoptotic fragments of eIF4G translation initiation factor family members eIF4GI and p97/DAP5/NAT1. J. Biol. Chem. 278, 3572-3579.
63. Henis-Korenblit, S., Strumpf, N.L., Goldstaub, D. & Kimchi, A. (2000) A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation. Mol. Cell Biol. 20, 496-506.
64. Henis-Korenblit, S., Shani, G., Sines, T., Marash, L., Shohat, G. & Kimchi, A. (2002) The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc. Natl Acad. Sci. USA 99, 5400-5405.
65. Geske, F.J., Lieberman, R., Strange, R. & Gerschenson, L.E. (2001) Early stages of p53-induced apoptosis are reversible. Cell Death Differ. 8, 182-191.
66. MacFarlane, M., Cohen, G.M. & Dickens, M. (2000) JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. Biochem. J. 348, 93-101.
67. Johnson, M.D., Xiang, H., London, S., Kinoshita, Y., Knudson, M., Mayberg, M., Korsmeyer, S.J. & Morrison, R.S. (1998) Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J. Neurosci. Res. 54, 721-733.
68. Denecker, G., Vercammen, D., Declercq, W. & Vandenabeele, P. (2001) Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci. 58, 356-370.
69. Sperandio, S., De Belle, I. & Bredesen, D.E. (2000) An alternative, nonapoptotic form of programmed cell death. Proc. Natl Acad. Sci. USA 97, 14376-14381.
70. Belmokhtar, C.A., Hillion, J. & Ségal-Bendirdjian, E. (2001) Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20, 3354-3362.
71. Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M. & Jäättelä, M. (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1009.
72. Jin, S., Kalkum, M., Overholtzer, M., Stoffel, A., Chait, B.T. & Levine, A.J. (2003) CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev. 17, 359-367.
73. Morley, S.J. & Pain, V.M. (2001) Proteasome inhibitors and immunosuppressive drugs promote the cleavage of eIF4GI and eIF4GII by caspase-8-independent mechanisms in Jurkat T cell lines. FEBS Lett. 503, 206-212.
74. Tee, A.R. & Proud, C.G. (2000) DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling. Oncogene 19, 3021-3031.
75. Wojcik, C. (1999) Proteasomes in apoptosis: villains or guardians? Cell. Mol. Life Sci. 56, 908-917.
76. Chen, F., Chang, D., Goh, M., Klibanov, S.A. & Ljungman, M. (2000) Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ. 11, 239-246.
77. MacLaren, A.P., Chapman, R.S., Wyllie, A.H. & Watson, C.J. (2001) p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ. 8, 210-218.
78. Kurland, J.F. & Meyn, R.E. (2001) Protease inhibitors restore radiation-induced apoptosis to Bcl-2-expressing lymphoma cells. Int. J. Cancer 96, 327-333.
79. Meyer, S., Kohler, N.G. & Joly, A. (1997) Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett. 413, 354-358.
80. Marienfeld, R., Neumann, M., Chuvpilo, S., Escher, C., Kneitz, B., Avots, A., Schimpl, A. & Serfling, E. (1997) Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur. J. Immunol. 27, 1601-1609.
81. Monney, L., Otter, I., Olivier, R., Ozer, H.L., Haas, A.L., Omura, S. & Borner, C. (1998) Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem. 273, 6121-6131.
82. Belaud-Rotureau, M.-A., Lacombe, F., Durrieu, F., Vial, J.-P., Lacoste, L., Bernard, P. & Belloc, F. (1999) Ceramide-induced apoptosis occurs independently of caspases and is decreased by leupeptin. Cell Death Differ. 6, 788-795.
83. Lopez-Marure, R., Ventura, J.L., Sanchez, L., Montano, L.F. & Zentella, A. (2000) Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels. Eur. J. Biochem. 267, 4325-4333.
84. Radford, I.R. (1999) Initiation of ionizing radiation-induced apoptosis: DNA damage-mediated or does ceramide have a role? Int. J. Radiat. Biol. 75, 521-528.
85. Dbaibo, G.S., Pushkareva, M.Y., Rachid, R.A., Alter, N., Smyth, M.J., Obeid, L.M. & Hannun, Y.A. (1998) p53-dependent ceramide response to genotoxic stress. J. Clin. Invest. 102, 329-339.
86. Oh, W.J., Kim, W.H., Kang, K.H., Kim, T.Y., Kim, M.Y. & Choi, K.H. (1998) Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cells. Cancer Lett. 129, 215-222.
87. Pruschy, M., Resch, H., Shi, Y.Q., Aalame, N., Glanzmann, C. & Bodis, S. (1999) Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. Br. J. Cancer 80, 693-698.
88. Ruvolo, P.P., Gao, F.Q., Blalock, W.L., Deng, X.M. & May, W.S. (2001) Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX. J. Biol. Chem. 276, 11754-11758.